1.Arnow, PM, Quimosing, EM, Beach, M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778–784.Google Scholar

2.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598–1601.CrossRefGoogle ScholarPubMed

3.Collignon, PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994;161:374–378.CrossRefGoogle Scholar

4.Relio, J, Ochagavia, A, Sabanes, E, et al.Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027–1030.Google Scholar

5.Smith, RL, Meixler, SM, Simberkoff, MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164–167.CrossRefGoogle ScholarPubMed

6.Percival, SL, Kite, P, Eastwood, K, et al.Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005;26:515–519.Google Scholar

7.Bleyer, AJ, Mason, L, Russell, G, Raad, II, Sherertz, RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005;26:520–524.Google Scholar

8.Rubinson, L, Wu, AW, Haponik, EF, Diette, GB. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol 2005;26:525–533.CrossRefGoogle Scholar

9.Engemann, JJ, Friedman, JY, Reed, SD, et al.Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control and Hospital Epidemiol 2005;26:534–539.Google Scholar

10.Morgan, J, Meitzer, MI, Plikaytis, BD, et al.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005;26:540–547.CrossRefGoogle ScholarPubMed

11.Maki, DG, Mermel, LA. Infections due to infusion therapy. In: Bennet, JV, Brachman, PS, eds. Hospital Infections. Philadelphia: Lippincott Raven; 1998:689–724.Google Scholar

12.Safdar, N, Maki, DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004;30:62–67.CrossRefGoogle ScholarPubMed

13.Crnich, CJ, Maki, DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: II. Long-term devices. Clin Infect Dis 2002;34:1362–1368.CrossRefGoogle ScholarPubMed

14.Sitges-Serra, A, Puig, P, Linares, J, et al.Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr 1984;8:668–672.Google Scholar

15.Raad, I, Costerton, W, Sabharwal, U, Sacilowski, M, Anaissie, E, Bodey, GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400–407.Google Scholar

16.Garland, JS, Alex, CP, Mueller, CD, et al.A randomized trial comparing povidone-iodine to a Chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431–1436.Google Scholar

17.Bouza, E, Burillo, A, Munoz, P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother 2001;13:224–233.Google Scholar

18.Carratala, J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001;7(suppl 4):83–90.Google Scholar

19.Capdevila, JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998;2:230–236.CrossRefGoogle ScholarPubMed

20.Safdar, N, Maki, D. The use of vancomycin lock and flush solutions for the prevention of catheter-related bloodstream infection. Presented at the 15th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.Google Scholar

21.Jurewitsch, B, Lee, T, Park, J, Jeejeebhoy, K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998;22:242–244.CrossRefGoogle ScholarPubMed

22.Dogra, GK, Herson, H, Hutchison, B, et al.Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13:2133–2139.Google Scholar

23.Chatzinikolaou, I, Zipf, TF, Hanna, H, et al.Minocycline-ethylenedi-aminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003;36:116–119.Google Scholar

24.Maki, DG, Crnich, CJ, Safdar, N. Ethanol lock solution for prevention of recurrent DTDR BSI. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Chicago, IL.Google Scholar

25.Kite, P, Eastwood, K, Sugden, S, Percival, SL. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004;42:3073–3076.CrossRefGoogle ScholarPubMed

26.Chaiyakunapruk, N, Veenstra, DL, Lipsky, BA, Saint, S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002;136:792–801.Google Scholar

27.Raad, II, Hohn, DC, Gilbreath, BJ, et al.Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.CrossRefGoogle ScholarPubMed

28.Berenholtz, SM, Pronovost, PJ. Barriers to translating evidence into practice. Curr Opin Crit Care 2003;9:321–325.Google Scholar

29.Maue, SK, Segal, R, Kimberlin, CL, Lipowski, EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. American Journal of Managed Care 2004;10:383–391.Google Scholar

30.Cabana, MD, Rand, CS, Powe, NR, et al.Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458–1465.CrossRefGoogle ScholarPubMed

31.Pathman, DE, Konrad, TR, Freed, GL, Freeman, VA, Koch, GG. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care 1996;34:873–889.Google Scholar

32.Davis, DA, Thomson, MA, Oxman, AD, Haynes, RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700–705.CrossRefGoogle ScholarPubMed

33.O'Grady, NP, Alexander, M, Dellinger, EP, et al.Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51(RR-10):1–29.Google ScholarPubMed

34.Berenholtz, SM, Pronovost, PJ, Lipsett, PA, et al.Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.Google Scholar

35.Rosenthal, VD, Guzman, S, Pezzetto, SM, Crnich, CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31:405–409.Google Scholar

36.Dopirak, M, Hill, C, Oleksiw, M, et al.Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 2002;23:721–724.CrossRefGoogle ScholarPubMed

37.Sexton, DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001;15:731–742, vii.CrossRefGoogle ScholarPubMed

38.Tokars, JI. Bloodstream infections in hemodialysis patients: getting some deserved attention. Infect Control Hosp Epidemiol 2002;23:713–715.Google Scholar

39.Reed, SD, Friedman, JY, Engemann, JJ, et al.Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:175–183.Google Scholar

40.Tokars, JI, Frank, M, Alter, MJ, Arduino, MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15:162–171.Google Scholar

41.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887–892.CrossRefGoogle ScholarPubMed